Change in serum PEDF level after pioglitazone treatment is independently correlated with that in HOMA-IR

International Journal of Cardiology

Volumn 172, Issue 1, 2014, Pages 244-246

  Tahara, Nobuhiro ^a   Matsui, Takanori ^a   Yamagishi, Sho Ichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; HOMA IR; Insulin resistance; PEDF

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVE C REACTIVE PROTEIN; PIGMENT EPITHELIUM DERIVED FACTOR; PIOGLITAZONE; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

AGED; BLOOD PRESSURE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIABETIC PATIENT; DOSE RESPONSE; DRUG DOSE TITRATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LETTER; MALE; MARKER CHROMOSOME; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; BLOOD; CARDIOVASCULAR DISEASES; DRUG EFFECTS; HOMEOSTASIS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

AGED; CARDIOVASCULAR DISEASES; EYE PROTEINS; FEMALE; HOMEOSTASIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PROSPECTIVE STUDIES; SERPINS; THIAZOLIDINEDIONES;

EID: 84894052594     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.289     Document Type: Article

References (14)

1. J. Tombran-Tink, C.G. Chader, and L.V. Johnson PEDF: pigment epithelium-derived factor with potent neuronal differentiative activity Exp Eye Res 53 1991 411 414
2. S. Yamagishi, T. Matsui, and K. Nakamura Atheroprotective properties of pigment epithelium-derived factor (PEDF) in cardiometabolic disorders Curr Pharm Des 15 2009 1027 1033
3. D.W. Dawson, O.V. Volpert, and P. Gillis et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis Science 285 1991 245 248
4. S. Yamagishi, and T. Matsui Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy Curr Pharm Biotechnol 12 2011 362 368
5. S.X. Zhang, J.J. Wang, G. Gao, C. Shao, R. Mott, and J.X. Ma Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor FASEB J 20 2006 323 325
6. S. Yamagishi, and T. Matsui Anti-atherothrombogenic properties of PEDF Curr Mol Med 10 2010 284 291
7. S. Yamagishi, H. Adachi, and A. Abe et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome J Clin Endocrinol Metab 91 2006 2447 2450
8. C. Chen, A.W. Tso, and L.S. Law et al. Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: a 10-year prospective study J Clin Endocrinol Metab 95 2010 5074 5081
9. M. Mizoguchi, N. Tahara, and A. Tahara et al. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta JACC Cardiovasc Imaging 4 2011 1110 1118
10. N. Tahara, S. Yamagishi, and A. Tahara et al. Adiponectin is inversely associated with ratio of serum levels of AGEs to sRAGE and vascular inflammation Int J Cardiol 158 2012 461 462
11. T. Yoshida, S. Yamagishi, and K. Nakamura et al. Pigment epithelium-derived factor (PEDF) ameliorates advanced glycation end product (AGE)-induced hepatic insulin resistance in vitro by suppressing Rac-1 activation Horm Metab Res 40 2008 620 625
12. S. Maeda, T. Matsui, M. Takeuchi, and S. Yamagishi Pigment epithelium-derived factor (PEDF) blocks advanced glycation end products (AGEs)-RAGE-induced suppression of adiponectin mRNA level in adipocytes by inhibiting NADPH oxidase-mediated oxidative stress generation Int J Cardiol 152 2010 408 410
13. N. Tahara, S. Yamagishi, and A. Tahara et al. Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans Atherosclerosis 219 2011 311 315
14. K. Nakamura, S. Yamagishi, H. Adachi, T. Matsui, Y. Kurita, and T. Imaizumi Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension Int J Cardiol 143 2010 96 98